Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Lung Resident Mesenchymal Stromal Cells in the Pathogenesis and Repair of Chronic Lung Disease
Declan Doherty, Lydia Roets, Anna Krasnodembskaya
Stem Cells (2023) Vol. 41, Iss. 5, pp. 431-443
Open Access | Times Cited: 21

Showing 21 citing articles:

METTL3-mediated m6A RNA methylation induces the differentiation of lung resident mesenchymal stem cells into myofibroblasts via the miR-21/PTEN pathway
Yi Lu, Zeyu Liu, Yunjiao Zhang, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 21
Stem cell-based therapy for fibrotic diseases: mechanisms and pathways
Marjan Taherian, Paria Bayati, Nazanin Mojtabavi
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Human Umbilical Cord–Mesenchymal Stem Cells Combined With Low Dosage Nintedanib Rather Than Using Alone Mitigates Pulmonary Fibrosis in Mice
Huijun Qiu, Rong Zhang, Daozhu Si, et al.
Stem Cells International (2025) Vol. 2025, Iss. 1
Open Access
Lung stem cells and respiratory epithelial chimerism in transplantation
Louise Bondeelle, Sophie Clément, Anne Bergeron, et al.
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240146-240146
Open Access
Idiopathic pulmonary fibrosis microenvironment: Novel mechanisms and research directions
Feng Gao, Lei Pan, Wei Liu, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114653-114653
Open Access
Understanding how methyltransferase-like 3 functions in lung diseases: From pathogenesis to clinical application
Deshuang Zhang, Zhixian Gou, Yi Qu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117421-117421
Open Access | Times Cited: 3
Beyond the Injury: How Does Smoking Impair Stem Cell-Mediated Repair Mechanisms? A Dual Review of Smoking-Induced Stem Cell Damage and Stem Cell-Based Therapeutic Applications
Mario Karam, Sarah Aqel, Mohammad Z. Haider, et al.
Stem Cell Reviews and Reports (2025)
Closed Access
Linking NLRP3 inflammasome and pulmonary fibrosis: mechanistic insights and promising therapeutic avenues
Shobhit Gairola, Antarip Sinha, Ravinder K. Kaundal
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 287-305
Closed Access | Times Cited: 8
In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary Fibrosis
Gabriel Escarrer-Garau, Aina Martín-Medina, Joan Truyols-Vives, et al.
Cells (2024) Vol. 13, Iss. 2, pp. 160-160
Open Access | Times Cited: 2
Roles of telocytes dominated cell–cell communication in fibroproliferative acute respiratory distress syndrome
Yonghua Zheng, Songshan Cai, Zongfeng Zhao, et al.
Clinical and Translational Discovery (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 2
Mesenchymal Stromal Cell Therapy in Lung Transplantation
Antti I. Nykänen, Mingyao Liu, Shaf Keshavjee
Bioengineering (2023) Vol. 10, Iss. 6, pp. 728-728
Open Access | Times Cited: 6
The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives
Sara Lettieri, F Bertuccio, Lucia Del Frate, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 547-547
Open Access | Times Cited: 5
Exosomal miRNA reprogramming in pyroptotic macrophage drives silica-induced fibroblast-to-myofibroblast transition and pulmonary fibrosis
Zhang Lin, Jiaqi Tian, Ning Li, et al.
Journal of Hazardous Materials (2024) Vol. 483, pp. 136629-136629
Closed Access | Times Cited: 1
Protective effects and mechanism of curcumin in animal models of pulmonary fibrosis: a preclinical systematic review and meta-analysis
F Hanyu, Hong Zheng, Jiaqi Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Wnt7b as a novel candidate in silico analysis of angiogenesis-related expressed genes in non-small cell lung cancer patients
Amin Soltanpor Dehkordi, Maryam Sayahinouri, Haniyeh Sadat Hosseininia, et al.
Iranian Journal of Blood and Cancer (2023) Vol. 15, Iss. 4, pp. 236-252
Open Access | Times Cited: 3
Stem Cells/Lung Organoids and Lung Rejuvenation in the Treatment of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema
Francesco Nucera, Philip M. Hansbro, Lauren H. Fairley, et al.
Elsevier eBooks (2024), pp. 94-114
Closed Access
STING-deficiency in lung resident mesenchymal stromal cells contributes to the alleviation of LPS-induced lung injury
Erming Zhao, Jiawen Chen, Dongbo Qiu, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 714, pp. 149973-149973
Closed Access
Role of TRIM59 in regulating PPM1A in the pathogenesis of silicosis and the intervention effect of tanshinone IIA
Cheng Peng, Yongbin Wang, Qian Wu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117014-117014
Open Access
Stem cell therapy for COVID-19 treatment: An umbrella review
Chaozhi Tang, Arkadiusz Dziedzic, Mahalaqua Nazli Khatib, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 10, pp. 6402-6417
Open Access
The Application of Mesenchymal Stem Cell Therapy in Treating Pulmonary Fibrosis: A Scoping Review
Evan Silverstein, Michael Richmann, Delaney Tyl, et al.
Cureus (2024)
Open Access
Impact of lung-resident Mesenchymal Stem Cells on Epithelial Wound Healing in Idiopathic Pulmonary Fibrosis
Aina Martín-Medina, Joan Truyols-Vives, Andreas Jahn, et al.
Research Square (Research Square) (2024)
Closed Access
Page 1

Scroll to top